ABEO Abeona Therapeutics Inc.

16.75
+0.25  (2%)
Previous Close 16.50
Open 16.65
Price To book 7.58
Market Cap 674811588
Shares 40,287,259
Volume 1,106,101
Short Ratio 7.90
Av. Daily Volume 975,394

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Noted July 18, 2017 that Phase 3 trial will commence in early 2018.
EB-101
Recessive dystrophic epidermolysis bullosa (RDEB)
Phase 2 enrollment commenced September 2016.
ABO-101
Recessive dystrophic epidermolysis bullosa (RDEB)
Phase 1/2 updated data released May 12, 2017.
ABO-102
Sanfilippo syndrome type A (MPS IIIA)

Latest News

  1. ETFs with exposure to Abeona Therapeutics, Inc. : September 18, 2017
  2. RBC Capital's Marc Harris breaks down his best biotech pi...
  3. Abeona Therapeutics (ABEO) Surges: Stock Moves 22.9% Higher
  4. How Should You Think About Abeona Therapeutics Inc’s (ABEO) Risks?
  5. ETFs with exposure to Abeona Therapeutics, Inc. : August 31, 2017
  6. Biotechs On The Move
  7. Abeona Therapeutics Receives FDA Breakthrough Therapy Designation for EB-101 Autologous Cell Therapy in Epidermolysis Bullosa
  8. Corporate News Blog - BioDelivery Sciences CEO Dr. Mark A. Sirgo to Retire at Year-End; Will Continue as Vice Chairman
  9. Abeona Therapeutics, Inc. :ABEO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017
  10. Edited Transcript of ABEO earnings conference call or presentation 22-Aug-17 2:00pm GMT
  11. Abeona Therapeutics to Host Gene Therapy R&D Day on October 11, 2017
  12. Abeona Therapeutics Announces Pivotal Expansion of ABO-102 Gene Therapy Clinical Trials in Sanfilippo Syndrome Type A
  13. Abeona Therapeutics reports 2Q loss
  14. Abeona Therapeutics Reports Second Quarter 2017 Financial Results and Recent Business Highlights
  15. Abeona Therapeutics Announces Appointment of Juan Ruiz as Chief Medical Officer
  16. Abeona Therapeutics Receives Guidance from FDA to Commence Pivotal Phase 3 for EB-101 Gene Therapy for Patients with Epidermolysis Bullosa
  17. ETFs with exposure to Abeona Therapeutics, Inc. : July 10, 2017
  18. Ahead of this year's MLB All-Star Game, here are 4 home r...
  19. Abeona Therapeutics (ABEO) Catches Eye: Stock Jumps 10.6%